Health Canada OKs AstraZeneca’s Evusheld drug for COVID-19 prevention

AstraZeneca’s Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

Previous post Ontario COVID numbers: 1,392 people in hospital, 177 in intensive care
Next post Amazon not adding crypto as payment option anytime soon, CEO says